According to a recent LinkedIn post from Glooko, the company is featuring its clinical leadership in a March 17 webinar hosted with Becker’s Healthcare focused on inpatient glycemic safety. The session is slated to include physicians from NYC Health + Hospitals, Hackensack Meridian Health, and Temple Health, highlighting practical strategies for frontline clinicians.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that discussion topics will include standardizing clinical workflows and aligning glycemic management with new Centers for Medicare & Medicaid Services reporting mandates for severe hypoglycemia and hyperglycemia. For investors, this emphasis on CMS-driven requirements may position Glooko as a potential partner for health systems seeking compliance-oriented digital tools in inpatient diabetes management.
By associating with prominent U.S. health systems and Becker’s Healthcare, the post suggests Glooko is working to strengthen its visibility among hospital decision-makers. If the webinar engagement translates into broader adoption of its platform or related services, it could support revenue growth and reinforce the company’s competitive stance in clinical data and glycemic management solutions.